BCL6B and neoplasm: Mechanistically, BCL6B promotes apoptosis via activation of caspase cascades and cleavage of poly (ADP-ribose) polymerase (PARP), and inhibits metastasis by upregulating tumor suppressors such as E-cadherin, OB-cadherin, HTATIP2, and TRPM1, while downregulating VEGFA.